GLOBAL CHOLERA VACCINES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Market Challenges And Opportunities

Global Cholera Vaccines Market- Drivers

• Increasing Vaccination Campaigns: Increasing vaccination campaigns by healthcare organizations such as the World Health Organization (WHO) and the United Nations Children’s Fund (UNICEF) are expected to drive the global cholera vaccines market over the forecast period. For instance, on March 8, 2023, the World Health Organization (WHO) and the United Nations Children’s Fund (UNICEF), a humanitarian aid organization, in coordination with health authorities, the Syria Immunization Group (SIG), and the Global Alliance for Vaccines (GAVI), kicked off a cholera vaccination campaign in earthquake-hit areas of northwest Syria. During the campaign, 1.7 million doses of cholera vaccine will be used to protect Syrians above one year of age, especially those living in the areas most severely impacted by the earthquake and at highest risk of cholera, including Sarmada, Maaret Tamsrin, Dana, and Atmeh districts in Idleb, and in A’zaz district in northern Aleppo.
• Increasing Fundings and Investments: Increasing adoption of inorganic growth strategies such as fundings and investments is expected to drive the global cholera vaccines market. For instance, In July 2022, the U.S. Agency for International Development (USAID) provided nearly US$ 1,180 million surge in humanitarian assistance that allowed USAID partners to provide critical aid for millions of people across the region. This funding includes urgent health support and investigations to identify potential diseases, such as cholera. As the risk for infectious disease increases when water sources are contaminated, USAID is providing water, sanitation, and hygiene support in drought-affected areas to include safe, potable water through water trucking, repaired water boreholes, community wells, and distribution systems.

Global Cholera Vaccines Market- Opportunities

• Increasing Educational Training Programmes: Increasing educational training programs regarding cholera vaccine manufacturing is expected to drive market growth over the forecast period. According to the data provided by the International Vaccine Institute (IVI), in December 2022, the International Vaccine Institute (IVI) conducted on-site training and consultation for Afrigen Biologics & Vaccines (Afrigen) in South Africa to help strengthen the company’s manufacturing capacity as part of the GLOBAL TRAINING HUB FOR BIO MANUFACTURING (GTH-B) PROGRAM and was funded by the Korean Ministry Of Health And Welfare. The training led by a team of senior IVI scientists provided education on overall production, including vaccine technology transfer, manufacturing-related safety, quality management system, and good laboratory practice (GLP).
• Potential for Combination Vaccines: Potential for combination vaccines could provide a great opportunity in the global cholera vaccines market. As per the World Health Organization (WHO), combination vaccines help reduce the number of injections given to a child and may improve vaccination coverage rates. This approach carries significant benefits, especially in low and middle-income countries where immunization resources are often constrained. Combination vaccines targeting cholera along with other endemic diseases in vulnerable regions can help improve both access and uptake of immunization in integrated vaccination programs.

Global Cholera Vaccines Market - Restraints

• Supply Shortage of Cholera Vaccine: The increasing cases of cholera infectious disease can increase the demand for cholera vaccine, which leads to the supply shortage of cholera vaccine and can hamper market growth over the forecast period.
• The increasing cases of cholera infectious diseases in Southern African countries such as Mozambique, Zimbabwe, and others can lead to high demand for cholera vaccines in the Southern African region, which was responsible for the shortage of cholera vaccines. Thus supply shortage of cholera vaccine can hamper the growth of market over the forecast period. For instance, according to data provided by Africa’s Public Health Agency, on February 3, 2023, Southern African countries with deadly cholera outbreaks had no immediate access to cholera vaccines, which leads to an increased in cholera infection. Therefore, the countries temporarily switched to use a single dose of cholera vaccine instead of double dose because of the supply shortage as outbreak of water-borne diseases such as cholera. Thus, the temporary supply shortage of cholera vaccine can hamper market growth over the forecast period.
• Counterbalance: Thus, key market players should focused on adoption of inorganic strategies such as supply and distribution agreements to meet the increasing demand for cholera vaccines